Potassium Carbonate → USRE48711, Example 72

HRID 1909480Notes

Reaction equation

HRID 1909480 reaction equation
Br[C:2]1[CH:7]=[CH:6][N:5]=[C:4]([C:8]([NH:10][C:11]2[CH:16]=[CH:15][CH:14]=[C:13]([C:17]3[N:21]([CH:22]4[CH2:24][CH2:23]4)[CH:20]=[N:19][CH:18]=3)[CH:12]=2)=[O:9])[CH:3]=1.B(O)O.C(=O)([O-])[O-].[K+].[K+]>C1(C)C=CC=CC=1>[CH:22]1([N:21]2[C:17]([C:13]3[CH:12]=[C:11]([NH:10][C:8]([C:4]4[CH:3]=[C:2]([C:3]5[CH:4]=[N:5][CH:6]=[CH:7][CH:2]=5)[CH:7]=[CH:6][N:5]=4)=[O:9])[CH:16]=[CH:15][CH:14]=3)=[CH:18][N:19]=[CH:20]2)[CH2:24][CH2:23]1

Participants

5

Conditions

Temperature
95 °C

Procedure

A suspension of 4-bromo-N-(3-(1-cyclopropyl-1H-imidazol-5-yl)phenyl)picolinamide (75.0 mg, 0.196 mmol), boronic acid (33.8 mg, 0.274 mmol), dppf(Pd)Cl2 (14.3 mg, 0.0196), potassium carbonate (81.3 mg, 0.588 mmol) in degassed toluene (1 mL), degassed water (0.5 mL) and degassed isopropanol (0.5 mL) was heated at 95° C. for 2 hours. The aqueous phase was discarded and the solvent removed under reduced pressure from the organic portion. Purification by reverse phase HPLC provided N-(3-(1-cyclopropyl-1H-imidazol-5-yl)phenyl)-3,4′-bipyridine-2′-carboxamide (17.3 mg, 23%) as a white solid.

Workup

  1. customdegassed water (0.5 mL)
  2. customdegassed isopropanol (0.5 mL)
  3. customthe solvent removed under reduced pressure from the organic portion
  4. customPurification by reverse phase HPLC

Sources & evidence

ORD record
ord-ea389f57ece34a399bdb9e01467d3040
Source dataset
uspto-grants-2013_12
Patent number
US08598360B2

Reaction notes

Loading…